Stifel
Tracked across 11 events · 202 articles · First seen Feb 02, 2026 · Last active Apr 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Stifel is acting as a joint bookrunning manager for Candel Therapeutics' public offering. Its participation is crucial for the successful execution of the offering.
Feb 19, 2026 · 9 articles
Business
Stifel, Nicolaus & Company, Incorporated, a subsidiary of Stifel, acted as a joint bookrunning manager for Palvella Therapeutics' public offering.
Feb 24, 2026 · 8 articles
Business
Stifel is acting as a joint book-running manager for Trevi Therapeutics' public offering, contributing to the successful execution of the share sale.
Apr 16, 2026 · 11 articles
Business
Stifel is acting as a joint book-runner for Compass Pathways' public offering, contributing to the successful execution of the share sale.
Feb 19, 2026 · 7 articles
Business
Stifel is serving as a joint book-running manager for the Xenon Pharmaceuticals offering, assisting in the distribution of the common shares and pre-funded warrants.
Mar 09, 2026 · 9 articles
+ 6 more events
View on Dashboard
70
Stifel acted as joint book-running manager Trevi TherapeuticsTrevi Therapeutics Prices...
60
Stifel acted as joint book-running manager Alamar BiosciencesAlamar Biosciences Upsized...
40
Stifel served as financial advisor The Metals CompanyThe Metals Company Nasdaq...
40
Stifel raised target price and gave 'buy' rating Monolithic Power SystemsMonolithic Power Systems...
Compass Pathways
joint book-runner
↔
Stifel
Stifel is a joint book-runner for Compass Pathways' public offering.
Candel Therapeutics
joint bookrunning manager
↔
Stifel
Stifel is a joint bookrunning manager for Candel Therapeutics' public offering.
NEWSDESK
Track Stifel live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard